guanabenz has been researched along with CACH Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbink, TEM; Bugiani, M; Dooves, S; Heine, VM; van der Knaap, MS; Wisse, LE | 1 |
1 other study(ies) available for guanabenz and CACH Syndrome
Article | Year |
---|---|
Bergmann glia translocation: a new disease marker for vanishing white matter identifies therapeutic effects of Guanabenz treatment.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Astrocytes; Biomarkers; Disease Models, Animal; Disease Progression; Guanabenz; Leukoencephalopathies; Mice; Phosphorylation; Treatment Outcome | 2018 |